Literature DB >> 10928125

Genetic alterations in human prostate cancer: a review of current literature.

M Ozen1, S Pathak.   

Abstract

We review the literature dealing with genetic alterations in human prostate cancer. We also discuss genetic predisposition and the roles of various proto-oncogenes and tumor-suppressor genes in prostate cancer initiation, progression, and metastasis. The role of telomere dynamics in prostate cancer metastasis and the induction of apoptosis is also briefly discussed.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10928125

Source DB:  PubMed          Journal:  Anticancer Res        ISSN： 0250-7005            Impact factor:   2.480


  9 in total

1.  Evidence of chromosomal instability in prostate cancer determined by spectral karyotyping (SKY) and interphase fish analysis.

Authors:  B Beheshti; P C Park; J M Sweet; J Trachtenberg; M A Jewett; J A Squire
Journal:  Neoplasia       Date:  2001 Jan-Feb       Impact factor: 5.715

2.  Genetic archaeology and the origins of the Irish population.

Authors:  D T Croke
Journal:  Ir J Med Sci       Date:  2000 Oct-Dec       Impact factor: 1.568

3.  Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium.

Authors:  M Stanbrough; I Leav; P W Kwan; G J Bubley; S P Balk
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-04       Impact factor: 11.205

4.  Genomic alterations indicate tumor origin and varied metastatic potential of disseminated cells from prostate cancer patients.

Authors:  Ilona N Holcomb; Douglas I Grove; Martin Kinnunen; Cynthia L Friedman; Ian S Gallaher; Todd M Morgan; Cassandra L Sather; Jeffrey J Delrow; Peter S Nelson; Paul H Lange; William J Ellis; Lawrence D True; Janet M Young; Li Hsu; Barbara J Trask; Robert L Vessella
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

5.  p53 expression controls prostate cancer sensitivity to chemotherapy and the MDM2 inhibitor Nutlin-3.

Authors:  William H Chappell; Brian D Lehmann; David M Terrian; Stephen L Abrams; Linda S Steelman; James A McCubrey
Journal:  Cell Cycle       Date:  2012-11-27       Impact factor: 4.534

6.  Down-regulation of Lsm1 is involved in human prostate cancer progression.

Authors:  S Takahashi; S Suzuki; S Inaguma; Y-M Cho; Y Ikeda; N Hayashi; T Inoue; Y Sugimura; N Nishiyama; T Fujita; T Ushijima; T Shirai
Journal:  Br J Cancer       Date:  2002-03-18       Impact factor: 7.640

7.  Resveratrol induces mitochondria-mediated, caspase-independent apoptosis in murine prostate cancer cells.

Authors:  Sanjay Kumar; Erdal Eroglu; James A Stokes; Karyn Scissum-Gunn; Sabita N Saldanha; Udai P Singh; Upender Manne; Selvarangan Ponnazhagan; Manoj K Mishra
Journal:  Oncotarget       Date:  2017-03-28

Review 8.  DNA microarrays in prostate cancer.

Authors:  Shuk-Mei Ho; Kin-Mang Lau
Journal:  Curr Urol Rep       Date:  2002-02       Impact factor: 2.862

9.  Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer.

Authors:  Hiroshi Fukuhara; Masami Kuramochi; Takeshi Fukami; Kohtaro Kasahara; Mutsuo Furuhata; Takahiro Nobukuni; Tomoko Maruyama; Kana Isogai; Takao Sekiya; Taro Shuin; Tadaichi Kitamura; Roger H Reeves; Yoshinori Murakami
Journal:  Jpn J Cancer Res       Date:  2002-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.